Sugi Predict

Sugi Predict / Targets / ZFX

ZFX

Zinc finger X-chromosomal protein · P17010 · ZFX on Sugi Atlas →

0 patent compounds predicted against ZFX, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ZFX by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome PHASE3UNKNOWN
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer PHASE1/PHASE2SUSPENDED
Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome PHASE2NOT_YET_RECRUITING
A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas PHASE2COMPLETED
Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency PHASE1RECRUITING
The Danish TURNER Cryopreservation Study nanRECRUITING
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies nanWITHDRAWN
Longitudinal Studies of Patient With FPDMM nanRECRUITING
Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in Therapy nanUNKNOWN
Better Delineation of YY1 Related Phenotype and Epigenetic Signatures. nanUNKNOWN
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood nanCOMPLETED
Endocrine, Metabolic, Cardiovascular and Immunological Aspects of Sex Chromosome Abnormalities in Relation to Genotype nanUNKNOWN
X-Chromosome Inactivation Status and Premature Ovarian Failure nanCOMPLETED
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Clinical Phenotyping and Characterization of Neural Networks and Cognitive Processes Involved in Mental Retardation X-linked nanUNKNOWN
Gene x Behavior Interaction in the Look AHEAD Study nanCOMPLETED
Detection of Krupple Like Factor -1(KLF1/ EKLF) DNA Mutations in Beta Thalassemia Patients nanNOT_YET_RECRUITING
Turner Syndrome: Genotype and Phenotype nanCOMPLETED
Genetic Causes of Male Infertility nanCOMPLETED
Molecular Associations With Reproductive Failure nanCOMPLETED
EKLF Gene Expression in β-thalassemia nanNOT_YET_RECRUITING
Study of Proteins in Head and Neck Cancer Cells nanCOMPLETED
Azoospermia Patients nanRECRUITING
Zinc and the Synthesis of Zinc Binding Proteins (Protocol B) nanCOMPLETED
Study of the Sex Differences in Inflammatory Diseases in Children nanUNKNOWN
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a ZFX binder may also engage these)

ProteinNameSimilarity
O62836 — 1.000 O62836 →
Q95LI3 — 1.000 Q95LI3 →
Q52V16 — 1.000 Q52V16 →
Q01611 — 0.998 Q01611 →
Q6B4Z5 — 0.998 Q6B4Z5 →
P17012 — 0.998 P17012 →
P08048 — 0.998 P08048 →
A2ANX9 — 0.996 A2ANX9 →
Q9Y462 — 0.993 Q9Y462 →
A7Y7X5 — 0.991 A7Y7X5 →
P20662 — 0.989 P20662 →
Q6GNP2 — 0.989 Q6GNP2 →
Q91853 — 0.987 Q91853 →
Q811F1 — 0.987 Q811F1 →
P10925 — 0.987 P10925 →
O95625 — 0.987 O95625 →
Q58DZ6 — 0.986 Q58DZ6 →
Q9QZP2 — 0.986 Q9QZP2 →
Q9UKN5 — 0.986 Q9UKN5 →
P07664 — 0.986 P07664 →
Q20082 — 0.986 Q20082 →
P25490 — 0.985 P25490 →
G5E8B9 — 0.985 G5E8B9 →
Q92010 — 0.985 Q92010 →
Q5XIU2 — 0.985 Q5XIU2 →
Q9VLK8 — 0.985 Q9VLK8 →
Q08875 — 0.984 Q08875 →
Q00899 — 0.984 Q00899 →
Q80V63 — 0.984 Q80V63 →
Q5U3T5 — 0.984 Q5U3T5 →